| Literature DB >> 35282025 |
Joseph Panzer1, Thierry Bové2, Kristof Vandekerckhove1, Daniël De Wolf1.
Abstract
Background: Coarctation of the Aorta (CoA) leads to increased morbidity and mortality later in life despite early surgical or percutaneous treatment. Many long-term complications are related to hypertension (HT) which is a common finding late after coarctation repair.Entities:
Keywords: Coarctation of the aorta; hypertension; long-term outcome
Year: 2022 PMID: 35282025 PMCID: PMC8905104 DOI: 10.21037/tp-21-418
Source DB: PubMed Journal: Transl Pediatr ISSN: 2224-4336
Figure 1Initial screening. *, PubMed, Cochrane Controlled Trials Register; **, records were excluded by a human not with any automation tools, except limiting by year of publication; no Controlled Trial had long-term BP data and/or included HT as an outcome measure; therefore all 117 trials were excluded; ***, 2 reports were not in English and were excluded. For more information, visit: http://www.prisma-statement.org/. BP, blood pressure; HT, hypertension.
Articles meeting inclusion criteria
| Author | Group | Standarized def. HT | Follow-up (in years) | Age at surgery | 24 h BP | Exercise test | Re-CoA or HAA data (%) | HT (%) | Surgery (%) | BAV (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| Bambul Heck ( | 273 | Yes | 31.4 (14.1–39.9) | 9.7 (0–56) | Yes | Yes | – | 70 | 100 | 48 |
| Brown ( | 819 | Yes* | 17.4±13.9 | 17.2±13.6 | No | No | – | 40 to >70** | 100 | – |
| Chen ( | 247 | Yes | 5.9 | S: 6 (0–55), | No | No | 31 re-CoA, 25.9 HAA | 69.6 | 81 | 56 |
| Choudhary ( | 151 | Yes | 26±13 | 5 (0–10) | No | No | 31 re-CoA | 44 | Mixed | 66 |
| Dijkema ( | 206 | Yes | 12.5 | 0.1 (0–17) | No | No | 21 HAA | 20 | 86 | 39 |
| Egbe ( | 546 | Yes | Age 33±9 | – | No | Yes | – | 60 | 87 | 57 |
| Giordano ( | 148 | Yes | 13.3±4.5 | 0.4 (0–11.8) | Yes | Yes | – | 44 | 100 | – |
| Lee ( | 834 | Yes | 27 [18–36] | 3 (0.1–15) | No | No | 59 re-CoA | 57 | 83 | 58 |
| Lillitos ( | 87 | Yes | 1.9 (0–9) | 0–5.6** | No | No | 15 re-CoA | 7–40** | 100 | – |
| Luitingh ( | 41 | Yes | 13±3 | 0.03 (0.02–0.1) | Yes | Yes | 32 HAA | 39 (12 on exercise test) | 100 | 61 |
| Martins ( | 75 | Yes | 9–12** | S 6 [1–26], | Yes | Yes | – | 30 S, 39 BD, 45 ST | Mixed | 79 S, |
| Mery ( | 343 | Yes | 12 (0.5–19) | 0.1 (0–0.75) | No | No | 33 HAA | 33 | 100 | – |
| Rinnström ( | 653 | Yes | 27.4±12.8 | 9.5±11 | No | No | 49 re-CoA | 52.7 | 94 | – |
| Róg ( | 58 | Yes | 20.39±9.8 | 8.7±8.6 | Yes | Yes | 39 re-CoA, 46 HAA | 48.3 | 86 | 62 |
| Sendzikaite ( | 90 | Yes | 8.5 (6–11.8) | 0.4 (0.05–2) | Yes | No | – | 46.7 | 71 | 54 |
| Smith-Parrish ( | 160 | Yes | 14 (4.6–36.7) | – | No | No | – | 22–38** | 86 | – |
| Wu ( | 2,295 | Not stated | Age 18–60 | – | No | No | – | 34.5 | – | – |
*, including self-reported HT; **, data divers in cohorts. HT, hypertension; BP, blood pressure; CoA, coarctation of the Aorta; HAA, hypoplastic aortic arch; BAV, bicuspid aortic valve; S, surgery; B, balloon dilatation; I, interventional treatment; BD, balloon dilatation; ST, stent.
Data acquisition from the included articles to investigate the etiology of HT after CoA-repair
| Author | Group | Patho-physiology of HT investigated? | Assessment central hemodynamics? | Assessment of arterial factors? | Assessment of cardiac factors? | Assessment of 3D aortic arch? | Retrospective data such as age at Rx and type of Rx |
|---|---|---|---|---|---|---|---|
| Bambul Heck ( | 273 | No | No | No | No | No | Yes |
| Brown ( | 819 | No | No | No | No | No | Yes |
| Chen ( | 247 | Yes | No | Only anatomical data | LV syst fx (MRI) | No | Yes |
| Choudhary ( | 151 | No | No | No | No | No | Yes |
| Dijkema ( | 206 | No | No | No | No | No | Yes |
| Egbe ( | 546 | Yes | No | Only anatomical data, CT/MRI | LV diast fx, LV mass (echo) | No | Limited data |
| Giordano ( | 148 | Yes | No | No | LV mass, LV syst and diast fx (echo) | No | Yes |
| Lee ( | 834 | No | No | No | No | No | Yes |
| Lillitos ( | 87 | No | No | No | No | No | Yes |
| Luitingh ( | 41 | Yes | Partially via carotid echo | Yes, carotid IMT, stiffness and distensibility, PWV | LV syst fx, LV mass (echo) | No | Yes |
| Martins ( | 75 | Yes | Yes, but not comprehensively | Aortic stiffness (applanation tonometry, MRI, PWV), endothelial fx (endo-PAT), biomarkers enothelial fx | LV mass, LV syst fx (MRI) | Yes | Limited |
| Mery ( | 343 | No | No | No | No | No | Yes |
| Rinnström ( | 653 | Yes with BMI | No | No | No | No | Yes |
| Róg ( | 58 | Yes | Partially via carotid echo | Anatomical data (echo), carotid IMT | LV mass, LV syst fx, LV diast fx (echo) | No | Yes |
| Sendzikaite ( | 90 | Yes also BMI | No | No | LV mass (echo) | No | Yes |
| Smith-Parrish ( | 160 | Yes with BMI | No | No | No | No | Yes |
| Wu ( | 2295 | No | No | No | No | No | Yes |
HT, hypertension; CoA, coarctation of the Aorta; MRI, magnetic resonance imaging; LV, left ventricle; CT, computed tomography; diast, diastolic; echo, transthoracic or transoesophageal; syst, systolic function; IMT, intima media thickness; PWV, pulse wave velocity; PAT, peripheral arterial tone; BMI, brain natriuretic peptide.